Skip to main content
logo
Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0716
0.00 (0.00%)
At close: Sep 21, 2026

Altamira Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Market Capitalization
00162730
Market Cap Growth
15.30%-72.84%-75.59%-78.93%-10.02%459.12%
Enterprise Value
115111830
Last Close Price
0.070.113.4897.00726.001048.00

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
PB Ratio
0.100.060.18-0.631.881.58
P/TBV Ratio
-0.190.45--3.46

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Debt / Equity Ratio
0.190.060.02-0.760.040.03
Net Debt / Equity Ratio
0.19-0.10-0.08-0.76-0.03-0.64
Net Debt / EBITDA Ratio
----1.160.082.04
Net Debt / FCF Ratio
-0.180.100.05-0.750.032.22
Quick Ratio
0.091.160.780.060.343.74
Current Ratio
0.111.321.380.140.843.83
Return on Equity (ROE)
-108.79%-118.79%--764.37%-44.88%-71.91%
Return on Assets (ROA)
-45.75%-48.12%-51.58%-26.97%-16.70%-21.99%
Return on Capital Employed (ROCE)
-115.40%-91.50%-81.40%83.60%-37.30%-29.70%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Earnings Yield
-1381.36%-2250.19%-311.15%-489.87%-69.52%-30.99%
FCF Yield
-1074.46%-1653.94%-925.68%-160.34%-55.73%-18.30%
Buyback Yield / Dilution
-351.86%-476.54%-978.83%-37.51%-120.26%-